Intervacc
Hägersten
About Intervacc
Intervacc develops vaccines based on recombinant proteins for use in animal health care. They focus on diagnostics in the animal health market and provide bacteriological and mycological analyzes.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $4.4M
- Last round: Grant (Aug 2023)
- Website: intervacc.se
- Phone: +08 120 10 600
Industries & Categories
Biotechnology, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/intervacc-2214827 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.